Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Ovid Therapeutics Inc | OVID | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
3.15 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 2.57 - 4.1389 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 3.15 | USD |
Ovid Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
222.74M | 70.71M | - | 392k | -52.34M | -0.74 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Ovid Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OVID Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.12 | 3.29 | 3.11 | 3.19 | 166,644 | 0.03 | 0.96% |
1 Month | 3.06 | 3.35 | 3.00 | 3.16 | 139,641 | 0.09 | 2.94% |
3 Months | 3.89 | 4.10 | 2.60 | 3.16 | 211,610 | -0.74 | -19.02% |
6 Months | 3.58 | 4.10 | 2.57 | 3.25 | 173,593 | -0.43 | -12.01% |
1 Year | 3.29 | 4.1389 | 2.57 | 3.47 | 200,102 | -0.14 | -4.26% |
3 Years | 3.67 | 4.80 | 1.405 | 3.37 | 224,452 | -0.52 | -14.17% |
5 Years | 1.96 | 10.45 | 1.405 | 3.97 | 653,491 | 1.19 | 60.71% |
Ovid Therapeutics Description
Ovid Therapeutics Inc is a biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering from epilepsies, seizure-related disorders, and neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life. |